The use of self infused intravenous immunoglobulin home therapy in the treatment of acquired chronic demyelinating neuropathies.
High dose intravenous immunoglobulin therapy is becoming the established maintenance treatment for several neurological conditions. Therapeutic immunoglobulin is expensive and its administration is time consuming. Efficacy is variable and must be closely monitored. Here, we show that self infused immunoglobulin at home, combined with daily functional strength diaries to predict dose and dosage intervals, is effective, time saving, and convenient for both patients and medical staff.
Sewell
W A
WA
Department of Immunology, John Radcliffe Hospital, Oxford, UK.
Brennan
V M
VM
Donaghy
M
M
Chapel
H M
HM
D003711:Demyelinating Diseases / Q000628:therapy*; D004334:Drug Administration Schedule; D018718:Home Infusion Therapy; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008499:Medical Records; D008875:Middle Aged; D010523:Peripheral Nervous System Diseases / Q000628:therapy*; D016896:Treatment Outcome
D016756:Immunoglobulins, Intravenous